Skip to Main Content
Try STAT+ TODAY
Trending:
First Opinion
STAT+
Coronavirus
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
The Pharmalot View
STAT+

‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues

  • Ed Silverman

By Ed Silverman Aug. 19, 2021

Reprints
Lisa Stockman Mauriello w/ fam
Lisa Stockman Mauriello and her family. Courtesy Lisa Stockman Mauriello

It’s been two weeks since Lisa Stockman Mauriello passed away and a lingering question, in my mind, is whether she died in vain.

I’d like to think not.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

Create a display name to comment

This name will appear with your comment

Former Merck CEO: Democracy and the drug industry are…
Former Merck CEO: Democracy and the drug industry are both in danger
Lessons from a thriving physical therapist to a younger…
Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis
Why doesn’t the U.S. have at-home flu tests?
Why doesn’t the U.S. have at-home flu tests?
‘Skinny labels’ on biosimilar medicines saved Medicare $1.5 billion…
‘Skinny labels’ on biosimilar medicines saved Medicare $1.5 billion over a recent five-year period
Pharmalittle: Second clinical trial death may be linked to…
Pharmalittle: Second clinical trial death may be linked to Eisai-Biogen Alzheimer’s drug; pharma presses the U.K.…
Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage
Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage

Recommended Stories